| Genetics of 35 blood and urine biomarkers in the UK Biobank N Sinnott-Armstrong, Y Tanigawa, D Amar, N Mars, C Benner, M Aguirre, ... Nature genetics 53 (2), 185-194, 2021 | 266 | 2021 |
| Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers N Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, JV Lindbohm, ... Nature medicine 26 (4), 549-557, 2020 | 217 | 2020 |
| FinnGen: Unique genetic insights from combining isolated population and national health register data MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, K Donner, ... MedRxiv, 2022.03. 03.22271360, 2022 | 78 | 2022 |
| The role of polygenic risk and susceptibility genes in breast cancer over the course of life N Mars, E Widén, S Kerminen, T Meretoja, M Pirinen, ... Nature communications 11 (1), 6383, 2020 | 61 | 2020 |
| Polygenic hyperlipidemias and coronary artery disease risk P Ripatti, JT Rämö, NJ Mars, Y Fu, J Lin, S Söderlund, C Benner, ... Circulation: Genomic and Precision Medicine 13 (4), e002725, 2020 | 49 | 2020 |
| Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health S Strausz, S Ruotsalainen, HM Ollila, J Karjalainen, T Kiiskinen, M Reeve, ... European Respiratory Journal 57 (5), 2021 | 48 | 2021 |
| Polygenic risk scores predict hypertension onset and cardiovascular risk F Vaura, A Kauko, K Suvila, AS Havulinna, N Mars, V Salomaa, FinnGen, ... Hypertension 77 (4), 1119-1127, 2021 | 32 | 2021 |
| How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ... Circulation: Genomic and Precision Medicine 15 (2), e003459, 2022 | 27 | 2022 |
| Genomic prediction of alcohol-related morbidity and mortality T Kiiskinen, NJ Mars, T Palviainen, J Koskela, JT Rämö, P Ripatti, ... Translational Psychiatry 10 (1), 23, 2020 | 23 | 2020 |
| 5-year versus risk-category-specific screening intervals for cardiovascular disease prevention: a cohort study JV Lindbohm, PN Sipilä, NJ Mars, J Pentti, S Ahmadi-Abhari, EJ Brunner, ... The Lancet Public Health 4 (4), e189-e199, 2019 | 22 | 2019 |
| Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies M Kivimäki, KA Walker, J Pentti, ST Nyberg, N Mars, J Vahtera, ... bmj 374, 2021 | 18 | 2021 |
| Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease-An observational follow-up study E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ... MedRxiv, 2020.09. 18.20197137, 2020 | 18 | 2020 |
| Patients with rheumatic diseases share similar patterns of healthcare resource utilization NJ Mars, AM Kerola, MJ Kauppi, M Pirinen, O Elonheimo, T Sokka-Isler Scandinavian Journal of Rheumatology 48 (4), 300-307, 2019 | 16 | 2019 |
| Genome-wide risk prediction of common diseases across ancestries in one million people N Mars, S Kerminen, YCA Feng, M Kanai, K Läll, LF Thomas, AH Skogholt, ... Cell genomics 2 (4), 2022 | 11 | 2022 |
| Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study JV Lindbohm, PN Sipilä, N Mars, A Knüppel, J Pentti, ST Nyberg, P Frank, ... The Lancet Digital Health 3 (7), e434-e444, 2021 | 10 | 2021 |
| Plasma proteins, cognitive decline, and 20‐year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies JV Lindbohm, N Mars, KA Walker, A Singh‐Manoux, G Livingston, ... Alzheimer's & dementia 18 (4), 612-624, 2022 | 9 | 2022 |
| Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers A Palomäki, A Palotie, J Koskela, KK Eklund, M Pirinen, S Ripatti, ... Annals of the Rheumatic Diseases 80 (12), 1530-1536, 2021 | 9 | 2021 |
| Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses H Sánez Tähtisalo, S Ruotsalainen, N Mars, K Porthan, L Oikarinen, ... Scientific Reports 10 (1), 1-12, 2020 | 9 | 2020 |
| Polygenic and clinical risk scores and their impact on age at onset of cardiometabolic diseases and common cancers NJ Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, ... bioRxiv, 727057, 2019 | 8 | 2019 |
| Predictive accuracy of a clinical and genetic risk model for atrial fibrillation S Khurshid, N Mars, CM Haggerty, Q Huang, LC Weng, DN Hartzel, ... Circulation: Genomic and Precision Medicine 14 (5), e003355, 2021 | 7 | 2021 |
